Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study

Summary

Background The metabolic basis of Alzheimer disease (AD) pathology and expression of AD symptoms is poorly understood. Omega-3 and -6 fatty acids have previously been linked to both protective and pathogenic effects in AD. However, to date little is known about how the abundance of these species is affected by differing levels of disease pathology in the brain. Methods and findings We performed metabolic profiling on brain tissue samples from 43 individuals ranging in age from 57 to 95 y old who were stratified into three groups: AD (N = 14), controls (N = 14) and “asymptomatic Alzheimer’s disease” (ASYMAD), i.e., individuals with significant AD neuropathology at death but without evidence for cognitive impairment during life (N = 15) from the autopsy sample of the Baltimore Longitudinal Study of Aging (BLSA). We measured 4,897 metabolite features in regions both vulnerable in the middle frontal and inferior temporal gyri (MFG and ITG) and resistant (cerebellum) to classical AD pathology. The levels of six unsaturated fatty acids (UFAs) in whole brain were compared in controls versus AD, and the differences were as follows: linoleic acid (p = 8.8 x 10−8, FC = 0.52, q = 1.03 x 10−6), linolenic acid (p = 2.5 x 10−4, FC = 0.84, q = 4.03 x 10−4), docosahexaenoic acid (p = 1.7 x 10−7, FC = 1.45, q = 1.24 x 10−6), eicosapentaenoic acid (p = 4.4 x 10−4, FC = 0.16, q = 6.48 x 10−4), oleic acid (p = 3.3 x 10−7, FC = 0.34, q = 1.46 x 10−6), and arachidonic acid (p = 2.98 x 10−5, FC = 0.75, q = 7.95 x 10−5). These fatty acids were strongly associated with AD when comparing the groups in the MFG and ITG, respectively: linoleic acid (p < 0.0001, p = 0.0006), linolenic acid (p < 0.0001, p = 0.002), docosahexaenoic acid (p < 0.0001, p = 0.0024), eicosapentaenoic acid (p = 0.0002, p = 0.0008), oleic acid (p < 0.0001, p = 0.0003), and arachidonic acid (p = 0.0001, p = 0.001). Significant associations were also observed between the abundance of these UFAs with neuritic plaque and neurofibrillary tangle burden as well as domain-specific cognitive performance assessed during life. Based on the regional pattern of differences in brain tissue levels of these metabolites, we propose that alterations in UFA metabolism represent both global metabolic perturbations in AD as well as those related to specific features of AD pathology. Within the middle frontal gyrus, decrements in linoleic acid, linolenic acid, and arachidonic acid (control>ASYMAD>AD) and increases in docosahexanoic acid (AD>ASYMAD>control) may represent regionally specific threshold levels of these metabolites beyond which the accumulation of AD pathology triggers the expression of clinical symptoms. The main limitation of this study is the relatively small sample size. There are few cohorts with extensive longitudinal cognitive assessments during life and detailed neuropathological assessments at death, such as the BLSA Conclusions The findings of this study suggest that unsaturated fatty acid metabolism is significantly dysregulated in the brains of patients with varying degrees of Alzheimer pathology.

Key Points

• 1Unsaturated fatty acid levels are significantly altered in Alzheimer disease patients
• 2The study includes a comparison of brain tissue from healthy controls and individuals with different levels of AD pathology
• 3Key fatty acids showed distinct trends based on cognitive performance and AD neuropathology
• 4The findings indicate that fatty acid metabolism could influence Alzheimer disease symptom expression
• 5The study has limitations due to a relatively small sample size and focus on post-mortem analysis.

Related articles

• Medical Terminologies

  This document provides a comprehensive list of medical terms related to patient statuses, conditions, tools, procedures, and commonly used prefixes in medical terminology. It serves as a reference for understanding various medical concepts and their meanings.

• Absolutely. I based this on the 4th edition of Essentials of

  Absolutely. I based this on the 4th edition of Essentials of Nursing Informatics that you uploaded. The book identifies Chapter 17 as “Theories, Models, and Frameworks” and Chapter 32 as “The Nursing

• Anatomy and Physiology of the Respiratory System

  This document provides a detailed overview of the anatomy and functions of the respiratory system, including structures, gas exchange mechanisms, and respiratory physiology. It covers both upper and lower respiratory tract components, physiological processes involved in breathing, and the impacts of various factors on respiratory health.

• Blood Vessels and Circulatory System Functions

  This document provides an extensive overview of blood vessel functions, classifications, structures, and the circulatory system's physiology. It details systemic and pulmonary circulation, highlighting the anatomy and roles of various arteries and veins.

• Functions and Anatomy of the Lymphatic and Immune Systems

  This document provides an overview of the lymphatic system's functions, anatomy, and its role in immunity, detailing structures such as lymphatic vessels, nodes, and organs. It also covers innate and adaptive immunity, including responses to foreign substances and the production of immune cells.